Resultados de la búsqueda 91-100 of 4554 for targeted supplements

1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Given the restricted expression profile, FAP is a promising target for peptide-targeted radionuclide imaging and therapeutic agents. Phase 1 of this study ...

2. Hematología - Ensayos clínicos - Mayo Clinic

   Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

3. Hematología - Ensayos clínicos - Mayo Clinic

   Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...

4. El folato (ácido fólico) - Mayo Clinic

   Folate: Fact sheet for health professionals. Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/Folate-HealthProfessional. Accessed Jan. 26, 2025.

5. Salud de la mujer LGBTQ health - Mayo Clinic

   Comprender los problemas de salud de las mujeres, lo que incluye los riesgos principales para la salud, la menopausia, la salud de las mamas y más.

6. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   In Part 1, different level of step-up doses are tested followed by the target dose of ABBV-383. In Part 2, the step-up dose identified in Part 1 will be used ...

7. Mayo Clinic Physician Update - July 2024

   Page 1.

8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...

9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

   Inotuzumab attaches to cancer cells in a targeted way and delivers calicheamicin to kill them. Other drugs used in the chemotherapy regimen, such as ...

10. Hematología - Ensayos clínicos - Mayo Clinic

    In Part 1, different level of step-up doses are tested followed by the target dose of ABBV-383. In Part 2, the step-up dose identified in Part 1 will be used ...